Ketamine and Crocin Exposure Modulate Anxiety, Depression, Memory, and Pain Processes in Adolescent Female Wistar Rats Publisher Pubmed



Alijanpour S ; Golshani SP ; Ebrahimighiri M ; Zarrindast MR ; Khakpai F
Source: Behavioural Pharmacology Published:2025

Abstract

Ketamine, a noncompetitive N-methyl- d -aspartate receptor antagonist, and crocin, the bioactive components of Crocus sativus L. , affect anxiety, depression, memory, and pain processes. It has not yet been clarified that crocin can potentiate the analgesic and antidepressant effects of ketamine, as well as attenuate the anxiogenic and amnesic impacts of ketamine in adolescent rodents. This study was designed to explain this issue in adolescent female Wistar rats. For this aim, elevated plus-maze, forced swim test, step-through, and tail-flick tests were utilized. The results indicated that the adolescent female Wistar rats' body weight increased across 10 days of drug treatment, but it did not differ between the groups. Pretreatment with ketamine [20 mg/kg, intraperitoneally (i.p.)] induced anxiogenic- and antidepressant-related behaviors, as well as amnesic and analgesic impacts in adolescent female Wistar rats. Furthermore, alone injection of crocin (30 mg/kg, i.p.) exerted an antidepressant-related behavior. When ketamine (20 mg/kg, i.p.) and crocin (30 mg/kg, i.p.) were coinjected, crocin could potentiate the analgesic and antidepressant effects of ketamine, as well as attenuate the anxiogenic and amnesic properties of ketamine in adolescent female Wistar rats. These results suggested that crocin causes a modulatory effect on ketamine's anxiogenic- and antidepressant-related behaviors, as well as amnesic and analgesic effects in adolescent female Wistar rats. This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine